OBJECTIVE: Disturbances in adipocyte lipolysis in obesity may contribute to elevated circulating non-esterified fatty acid (NEFA) concentrations and insulin resistance. In experimental models, NEFA metabolism is influenced by adipocyte proteins such as adipocyte and keratinocyte lipid binding proteins (aP2=ALBP and mal1=KLBP) and fatty acid translocase (CD36). We investigated the effect of obesity and weight loss on the expression of these proteins in human subcutaneous adipose tissue. STUDY DESIGN AND SUBJECTS: Subcutaneous adipose tissue was obtained from 12 obese (body mass index (BMI) 42.4 AE 1.6 kg=m 2 ) and 12 lean (23.4 AE 0.6 kg=m 2 ) subjects. The obese subjects underwent gastric banding and biopsies were taken again after 2 y following a significant weight reduction (BMI 32.8 AE 1.4 kg=m 2 ). Adipose tissue proteins were quantified by Western blotting. RESULTS: Differential expression of ALBP, KLBP and CD36 was observed in lean and weight-reduced subjects compared with obese individuals. This resulted in a significantly lower ALBP=KLBP ratio in lean and weight-reduced individuals compared to obese subjects. Furthermore there was a significant influence of gender on this ratio. Moreover, the commonly used internal standard protein actin was expressed significantly higher in lean compared to obese individuals. CONCLUSION: The relative content of ALBP and KLBP in human adipose tissue changes with obesity, weight loss and gender indicating differential regulation. Differing responses in the expression patterns of adipose tissue proteins capable of binding NEFAs in response to weight changes suggest a potential importance in the development of obesity-associated complications.
Introduction
Elevated plasma non-esterified fatty acids (NEFA) concentrations are believed to play a key role in the development of insulin resistance, non-insulin-dependent diabetes mellitus and atherosclerosis, all of which are associated with obesity. The exact mechanisms underlying this phenomenon are unknown, but are believed to involve changes in lipid and glucose metabolism in liver and adipose tissue. 1 NEFAs are stored in the form of triacylglycerol (TG) primarily in adipose tissue and therefore disturbances in either storage or mobilization of NEFAs may change fat cell accumulation. A variety of cellular processes are regulated by NEFAs, but most cells have limited or no capacity to synthesize them and are dependent on direct uptake from the circulation. One of the putative transmembrane fatty acid transporters is fatty acid translocase (FAT), identical to the leukocyte differentiation antigen CD36. 2 Defective CD36 has been shown to be the underlying cause of the insulin resistance that presents in the spontaneously hypertensive rat 3 and human studies have revealed a link between mutations in the CD36 gene and defective long-chain FA accumulation in the heart. 4 Furthermore, compared with wild-type animals, CD36 knockout mice display elevated serum NEFA concentrations and reduced FA uptake in heart, skeletal muscle and adipose tissue, 5, 6 while mice with muscle-specific overexpression of CD36 have reduced plasma NEFA concentrations and an increased ability of muscle to oxidize FAs. 7 For reasons of both insolubility and toxicity NEFAs in the blood are bound mainly to albumin and within the cell to cytoplasmic fatty acid binding proteins (FABPs), a family of 14 -15 kDa proteins. 8 Two FABPs are expressed in mouse and human white adipose tissue, adipocyte lipid binding protein (ALBP, the human homologue of the mouse protein aP2) and keratinocyte lipid binding protein (KLBP, the human homologue of mouse mal1). The genetic absence of aP2 in mice results in significant protection from obesity-induced insulin resistance, irrespective of whether the obesity is dietary 9 or genetically induced. 10 Recent studies have also demonstrated a strong protection against atherosclerosis in the aP2-deficient animals. 11 In wild-type mice, mal1 protein is expressed at levels approximately 1 -5% of that of aP2. 12, 13 Interestingly, adipocytes from aP2 knock-out mice have a strong induction of mal1 expression and exhibit diminished lipolysis compared to wild-type adipocytes. 12, 13 These data suggest that aP2=ALBP and possibly mal1=KLBP could be of importance for the non-hormonal regulation of adipose tissue lipolysis and insulin resistance. Furthermore, some FABPs can localize to the nucleus and may modulate the activity of transcription factors such as peroxisome proliferator-activated receptors (PPARs). 14 The molecular mechanisms in adipose tissue underlying obesity-related complications are unknown, but may depend on alterations in the lipolytic cascade leading to impaired hormone sensitive lipase activity. 15 However, it is also conceivable that expression of non-hormonally regulated proteins with a role in NEFA metabolism, such as FABPs and CD36, are altered in obesity, hence contributing to the phenotype. Although these proteins have been shown to play important roles in metabolic control in mouse models, to date very little is known about the expression of these proteins in human obesity. Therefore the aim of this study was to compare subcutaneous adipose tissue from lean and obese subjects in terms of the expression levels of ALBP, KLBP and CD36. In addition, we investigated expression of these proteins in the obese subjects after substantial weight reduction.
Subjects and methods

Subjects
All subjects were otherwise healthy Caucasians born in Sweden. Detailed clinical characteristics are displayed in Table 1 . Adipose tissue from obese subjects was obtained from patients undergoing weight-reduction surgery with adjustable gastric banding. The lean subjects were undergoing elective surgery for uncomplicated inguinal hernia or gallstone. All subjects fasted overnight and subcutaneous abdominal adipose tissue (1 -2 g) was taken from the surgical wound within 30 min of the start of the operation. Only saline was administered until the tissue pieces were taken. Surgical anaesthesia was given as previously described. 16 Obese subjects were subsequently followed up at 2 y (26.7 AE 0.6 months) post-operation and a subcutaneous fat biopsy was obtained from the abdominal region as described previously. 17 The weight reduction intervention was effective, as demonstrated by an approximate 25% weight loss (body weights of 128.9 AE 3.7 and 100.3 AE 5.8 kg before and after weight reduction, respectively). All women were premenopausal and were not taking any oral contraceptive. All tissue pieces were frozen in liquid nitrogen and stored at 770 C for subsequent analysis. Before surgery, a venous blood sample was taken from the subjects following an overnight fast for measurement of plasma glucose, triacylglycerol, NEFA and cholesterol concentrations by the hospital routine chemistry laboratory and serum insulin by radio-immunoassay (Amersham Pharmacia, Uppsala, Sweden). For a subset of subjects mean cell volumes of isolated adipocytes were determined 18 as follows: lean 500 AE 46 (n ¼ 9); obese 900 AE 40 (n ¼ 11); weight-reduced 543 AE 54 (n ¼ 12) pl (P 0.0001 for obese vs both lean and weight-reduced subjects). The study was approved by the Local Ethics Committee of Karolinska Institutet (Stockholm, Sweden). All subjects gave informed consent to participate in the study. The protein content in each sample was determined using a kit of reagents from Pierce, Rockford, IL, USA. Thirty micrograms of total protein were loaded on 15% polyacrylamide gels and separated by standard SDS -polyacrylamide gel electrophoresis. To control for differences in gel migration, exposure time, antibody incubation etc, samples to be compared were run on the same gels and transferred to the same PVDF membranes (Amersham Pharmacia Biotech, Little Chalfont, UK). Protein transfer was checked by standard Coomassie staining of the gels. Following a standard blocking procedure, blots were incubated in the presence of a polyclonal antibody directed against human ALBP or KLBP (dilutions of 1:3000 and 1:3300, respectively, both generated in rabbit, kindly provided by Drs Rex Parker and Haris Jamil of Bristol Myers Squibb, Lawrenceville, NJ, USA),
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CD36 (at a dilution of 1:150, Santa Cruz Biotech, CA, USA, catalogue number sc-5523, generated in goat) or actin (at a dilution of 1:250, Sigma, St Louis, MO, USA, catalogue number A2066, generated in rabbit). Anti-rabbit and antigoat antibodies (used at dilutions of 1:2000 and 1:4000, respectively) conjugated to horseradish peroxidase were from Sigma, St Louis, MO, USA. Antigen -antibody complexes were detected by chemiluminescence using a kit of reagents from ECL (Amersham Pharmacia, Little Chalfont, UK) and blots were exposed to high-performance chemiluminescence film (Amersham Pharmacia, Little Chalfont, UK). Films were scanned and the optical density of each specific band determined using the Fuji LAS-1000 system and Image Gauge version 3.0 software (Fuji, Tokyo, Japan). For quantification with each antibody, the total intensity (in arbitrary units) of all the specific bands for each membrane was set to 100% and the intensities of the individual sample bands were expressed as a percentage of the total. Thus the units in which the quantified proteins are presented are percentages. To validate that the signal was in the linear range several films exposed at different time intervals were analysed. In addition, comparisons were made between results obtained by scanning the films and by determining directly the chemiluminescence of the same blot using the Fuji LAS-1000 system. Antibodies display different affinities, sensitivities and levels of detection for their cognate epitopes. Since purified protein standards (which would allow conversion of the measured intensities to molar concentrations) were not available, comparison between expression levels of the different proteins using the present methodology was not possible. For example no inference can be made about the molar ratio of FABPs from the ALBP=KLBP ratios presented. While comparison of protein expression quantified in samples on different Western blots is not possible, comparison between samples analysed on the same membrane is valid. However, the samples from the obese subjects were run on two separate gels and the correlations between the two blots for the different proteins quantified were 0.85 -0.96, indicating significant reproducibility.
Statistical analysis
Groups were compared with the paired or unpaired Student's t-test as indicated. A two-way ANOVA was used to determine the influence of sex on the measured values and post-hoc analysis was performed with Fisher's PLSD. All results are presented as mean AE s.e.m. Statistical analysis was assigned to a P-value of < 0.05. Correlations were performed with the Spearman rank correlation test.
Results
Clinical material
Subcutaneous adipose tissue biopsies were taken from 12 lean subjects and 12 obese individuals. Biopsies were retaken from the obese subjects following a 2 y period of weight reduction by means of gastric banding. Detailed clinical characteristics are shown in Table 1 .
Expression of ALBP, KLBP, CD36 and actin in adipose tissue from lean and obese men and women Adipose tissue expression of ALBP, KLBP, CD36 and actin proteins was quantified by Western blot analysis, as shown in Figure 1 . Expression of ALBP was no different in subcutaneous adipose tissue from lean and obese subjects, but KLBP expression was 3.2-fold higher (P < 0.0001) in the lean subjects (Table 2) . Consequently the ALBP=KLBP ratio was 3.5 fold lower in the lean subjects (P ¼ 0.0002). CD36 expression was not different between the two subject groups (Table 2) . Actin is a commonly used cellular control protein since it is assumed to be invariantly expressed. However, we observed an approximately 3-fold higher expression of actin in lean compared to obese individuals (P ¼ 0.0002, Table 2 ). 
To investigate possible influences of sex on protein expression, analysis by ANOVA was performed (Table 3) . This revealed a significant interaction of gender with the differences in the ALBP=KLBP ratio and CD36 expression between lean and obese subjects. Although the increase in the ALBP=KLBP ratio in obesity was observed in both genders, it was greater in men than in women (P ¼ 0.011 interaction between sex and lean=obese status by ANOVA). In contrast, there was a differential effect of sex on the expression of CD36 with obese men displaying a lower expression and obese women showing a greater expression of CD36 compared with their lean counterparts (P ¼ 0.0005 interaction between sex and lean=obese status by ANOVA). When expressing CD36 relative to actin the interaction between sex and lean=obese status was no longer observed (P ¼ 0.95). Post-hoc analyses revealed gender differences in both lean and obese groups for CD36 expression and the ALBP=KLBP ratio. Neither ALBP nor KLBP expression was significantly influenced by gender irrespective of whether the proteins were expressed in absolute amounts or relative to actin (Table 3) .
Expression of PPARg protein in the adipose tissue biopsies was also investigated by Western blotting. However, PPARg could only be reproducibly detected in samples from the obese subjects, with only three out of the 12 lean subjects displaying quantifiable expression. This prevented performance of reliable statistical analysis and therefore these results are not presented.
Expression of ALBP, KLBP, CD36 and actin in adipose tissue from obese individuals before and after weight loss We next investigated protein expression of ALBP, KLBP, CD36 and actin in the same set of 12 obese subjects following a 2 y period of weight reduction. Although the patients displayed a significant reduction in BMI, they were still obese with a mean BMI of 32.8 AE 1.4 kg=m 2 ( Table 1) . ALBP and KLBP expression were 1.5-and 2.1-fold greater, respectively, in subcutaneous adipose tissue from the obese subjects following a 2 y period weight reduction (both P < 0.0001), consequently the ALBP=KLBP ratio decreased 1.6-fold (P < 0.02) with the weight loss (Table 4) . CD36 expression was reduced 1.6-fold following the weight loss (P < 0.008), while actin expression was not significantly different between the two groups (P ¼ 0.30, Table 4 ). When expressing proteins relative to actin the following values were obtained: ALBP=actin 0.92 AE 0.18 vs 1.45 AE 0.13, P ¼ 0.014; KLBP=actin 0.63 AE 0.06 vs 1.70 AE 0.18, P ¼ 0.0002; CD36=actin 1.42 AE 0.22 vs 0.96 AE 0.15 P ¼ 0.11 for subjects before and after weight reduction, respectively. There was no significant effect of gender on the changes in expression of these proteins as analysed by ANOVA.
Relationships of adipose tissue fatty acid handling protein content and circulating NEFA concentration There were no significant correlations between fasting NEFA concentrations and adipose tissue expression of ALBP or Fatty acid handling proteins in obesity RM Fisher et al KLBP alone, the ALBP=KLBP ratio or CD36 in either lean, obese or weight-reduced subjects (data not shown).
Discussion
The mechanisms behind the disturbances in NEFA metabolism associated with obesity, insulin resistance and noninsulin-dependent diabetes mellitus remain unclear. Adipose tissue is the tissue primarily responsible for regulating circulating NEFA concentrations, both taking up and releasing NEFAs according to the nutritional state of the individual. 1 Investigation of the effects of obesity on the expression of NEFA-handling proteins within adipose tissue may provide insights into the associated disturbances in NEFA metabolism. Semi-quantitative Western blot studies on protein expression have often utilized other cellular proteins as invariant controls in order to standardize for differences in loading and transfer. Actin is perhaps the most commonly used protein in this respect and we ourselves have used it in a recent publication. 18 In that study we compared actin expression within, rather than between, subjects with similar BMI and found only small variations in actin expression. However, here we show that there are substantial differences in the expression levels of actin in subcutaneous adipose tissue from lean and obese individuals. This somewhat unexpected result could result from the marked differences in cell size between adipocytes from lean and obese individuals. Still, this is less likely since we observed a similar actin expression in obese subjects before and after weightreduction, despite a pronounced difference in adipocyte size. At present we have no explanation for the observed difference in actin expression between lean and obese subjects, but we conclude that data in which proteins are expressed relative to actin should be interpreted with caution. Similar discretion should be employed when considering RNA expression relative to actin, as addressed recently. 20 We have therefore in the following discussion focused on our results where proteins are expressed in absolute terms. It is of note that a major finding in this study, namely the results relating to the ALBP=KLBP ratio are unaffected by expression relative to actin (since the denominator of actin is cancelled out in this ratio).
Expression of the adipose tissue FABPs (ALBP and KLBP) has been shown to differ between human subcutaneous and visceral adipose tissue depots. 18 Such differences in expression pattern might be involved in determining the different basal (non-hormonally stimulated) rates of lipolysis observed in these depots. 21 The ALBP=KLBP ratio was higher in subcutaneous compared to visceral fat from both lean and obese subjects. However, this appeared to be due to different relative changes in FABP expression between the lean and obese groups, 18 indicating that there are differential alterations in ALBP and KLBP expression associated with obesity. The present data offer further support to this idea since there were differential changes in ALBP and KLBP expression in subcutaneous adipose tissue from both lean and weight-reduced individuals compared to obese subjects, resulting in a higher ALBP=KLBP ratio in the latter subject group.
Recent evidence demonstrates the potential importance of fatty acid handling proteins in coordinating lipid storage and mobilization since ALBP interacts directly with hormone sensitive lipase (HSL) and increases its activity and substrate availability. 22 Whether KLBP has a similar role remains to be established. However, due to differing fatty acid binding affinities and surface charge patterns of ALBP and KLBP it is likely that these two FABPs will interact differently with intracellular targets such as HSL. It is therefore tempting to speculate that the relative expression of ALBP and KLBP could at least in part explain the observed differences in lipolysis between lean and obese subjects 23 and between subcutaneous and omental adipose tissue. 21 Of course in the absence of purified FABP protein controls, the molar relationship between ALBP and KLBP cannot be inferred from the present results.
The CD36-content of epididymal adipose tissue has been found to be modestly increased in obese compared to lean Zucker rats. 24 The expression of CD36 in the present study was more difficult to interpret. When we compared absolute amounts of CD36 no difference was observed between obese and lean individuals. However, if CD36 was expressed relative to actin a significant difference became apparent. Similarly different results were obtained if CD36 levels before and after weight reduction were expressed in absolute terms or relative to actin. Thus, CD36 was significantly lower in the weightreduced state when expressed in absolute terms. A similar The difference between these values and those given for the obese subjects in Table 2 is explained by the fact that the proteins are expressed as a percentage of the proteins analysed on the same Western blot (as described in Methods). Since the samples from the obese subjects in Tables 2 and 4 were analysed on blots with either lean or weight-reduced individuals respectively, the sum of the band intensities is different. Therefore comparisons between the data in Tables 2 and 4 should not be made. Furthermore, no information as to molar ratios can be inferred from these data.
Fatty acid handling proteins in obesity RM Fisher et al trend was seen for CD36=actin, but this difference was not statistically significant. In the absence of a proven invariant protein standard we are prevented at this time from drawing any firm conclusions as to the true alterations in CD36 expression associated with obesity and weight loss. The influence of gender on the ALBP=KLBP ratio is intriguing and has to our knowledge not been previously demonstrated for other proteins in adipose tissue. It is possible that it is related to sex-dependent changes in adipose tissue lipolysis rates and=or differences in the expression of other proteins with important roles in adipose tissue fatty acid metabolism. 25 A recent report showed that following weight reduction HSL mRNA levels decreased in obese women, but not in men. 26 This observation is likely to be of physiological importance since adipocytes from obese women, but not men, display reduced lipolytic activity after weight reduction. 27 Thus, at least some genes display gender-specific regulation in obese subjects before and after weight loss. This might result in altered adipocyte function. However, the involvement of sex hormones, either directly or indirectly, remains to be established. The influence of gender on the expression of CD36 was highly significant when CD36 was expressed in absolute amounts, but it should be borne in mind that this effect was lost when expressed relative to actin making further speculation difficult.
Even though our analyses were performed on adipose tissue, we believe that our results predominantly represent adipocyte expression. Previous reports from our group have demonstrated that adipose tissue protein is derived to an overwhelming extent from the adipocytes themselves and not from the stroma-vascular portion. 19 However, in the absence of immunohistochemistry data we cannot exclude the possibility that the proteins studied in this report may have a differential expression within specific cellular populations in adipose tissue.
Although there were no significant correlations between fasting NEFA concentrations and the expression of ALBP, KLBP or CD36, this does not exclude the possibility of an underlying association. Due to the well-known variability in NEFA concentrations, 28 it could be argued that a single NEFA measurement is a poor reflection of total fatty acid handling in the body. Indeed, the importance of these proteins in NEFA metabolism has already been suggested by a number of animal studies. 5 -7,9,10 In conclusion, our data show that proteins involved in human NEFA metabolism are differentially regulated in obesity and following weight reduction. The potential clinical importance of these changes remains to be established, but is in line with the putative role of NEFAs and their metabolism in the development of obesity-associated complications.
